Related Experiment Video
Updated: Aug 24, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Translational regulation by the p210 BCR/ABL oncoprotein
Danilo Perrotti1, Bruno Calabretta
1Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University, Columbus OH 43210, USA. perrotti-1@medctr.osu.edu
Abstract:
The ability of oncogenic proteins to regulate the rate of translation of specific mRNA subsets may be a rapid and efficient mechanism to modulate the levels and, in many cases, the activity of the corresponding proteins. In the past few years, we have identified several RNA binding proteins with translation regulatory activity whose expression is markedly activated in the blast crisis of chronic myelogenous leukemia, which represents the most malignant disease stage. Perturbation of the activity of some RNA binding proteins suppresses the leukemogenic potential of BCR/ABL-expressing cells. Most importantly, we have identified some of the targets of these RNA binding proteins. Two of these targets, c/ebp alpha and mdm2 mRNAs, are directly relevant for the altered differentiation and survival of leukemic cells. The identification of mRNA targets translationally regulated by RNA binding proteins overexpressed in tumor cells may lead to the development of therapeutic strategies aimed at modulating the translation rate of specific mRNAs.
Insights
Oncogenic proteins regulate mRNA translation to control protein levels. Targeting RNA-binding proteins in chronic myelogenous leukemia may offer new therapeutic strategies for leukemic cell survival and differentiation.
Area of Science:
- Molecular Biology
- Cancer Biology
- Hematology
Background:
- Oncogenic proteins can rapidly modulate protein levels by regulating specific mRNA translation rates.
- RNA-binding proteins with translation regulatory activity are upregulated in the blast crisis of chronic myelogenous leukemia (CML).
- CML blast crisis represents the most aggressive stage of the disease.
Purpose of the Study:
- To investigate the role of RNA-binding proteins in CML pathogenesis.
- To identify specific mRNA targets regulated by these proteins.
- To explore therapeutic strategies targeting these regulatory mechanisms.
Main Methods:
- Identification and characterization of RNA-binding proteins overexpressed in CML blast crisis.
- Analysis of mRNA targets translationally regulated by these proteins.
- Perturbation of RNA-binding protein activity in BCR/ABL-expressing cells.
Main Results:
- Several RNA-binding proteins with translation regulatory activity were identified in CML blast crisis.
- Perturbing the activity of these proteins reduced the leukemogenic potential of BCR/ABL-expressing cells.
- Key mRNA targets, including c/ebp alpha and mdm2, were identified, which are relevant to leukemic cell differentiation and survival.
Conclusions:
- RNA-binding proteins play a significant role in CML progression by regulating translation of specific mRNAs.
- Targeting these RNA-binding proteins or their mRNA targets presents a potential therapeutic avenue for CML.
- Modulating translation rates of specific mRNAs could be a novel strategy for cancer therapy.
Related Concept Videos
Leaky Scanning
Negative Regulator Molecules
Translational Regulation
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

